We are live on ! Find out more
2

2Xideas Portfolio holdings

AUM $255M
1-Year Est. Return 0.46%
This Fund
S&P 500
This Quarter Est. Return
+15.4%
1 Year Est. Return
+0.46%
3 Year Est. Return
+33.96%
5 Year Est. Return
+43.71%
10 Year Est. Return
AUM
$933M
AUM Growth
+$29.3M
Cap. Flow
-$89.1M
Cap. Flow %
-9.55%
Top 10 Hldgs %
41.1%
Holding
60
New
2
Increased
16
Reduced
34
Closed
8

Top Buys

Rank Stock Value
1
BAM icon
Brookfield Asset Management
BAM
+$18.1M
2
CERT icon
Certara
CERT
+$10.9M
3
TER icon
Teradyne
TER
+$9.85M
4
STZ icon
Constellation Brands
STZ
+$5.1M
5
FERG icon
Ferguson
FERG
+$4.07M

Top Sells

Rank Stock Value
1
MORN icon
Morningstar
MORN
+$12.8M
2
CYBR
CyberArk
CYBR
+$12.6M
3
MTCH icon
Match Group
MTCH
+$11.3M
4
JBTM
JBT Marel
JBTM
+$10.7M
5
EL icon
Estee Lauder
EL
+$9.54M

Sector Composition

Rank Sector Weight
1 Healthcare 28.52%
2 Technology 26.33%
3 Financials 18.83%
4 Industrials 9.13%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERT icon
26
Certara
CERT
$1.21B
$13.1M 1.4%
+743,511
New +$10.9M
CRL icon
27
Charles River Laboratories
CRL
$10.8B
$13M 1.4%
55,164
-3,467
-6% -$682K
COO icon
28
Cooper Companies
COO
$13.9B
$12.9M 1.38%
135,976
+4,660
+4% +$391K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$123B
$12.6M 1.36%
31,089
-3,870
-11% -$1.43M
MELI icon
30
Mercado Libre
MELI
$93.9B
$12.6M 1.35%
8,017
-958
-11% -$1.36M
ISRG icon
31
Intuitive Surgical
ISRG
$128B
$12.5M 1.34%
36,986
+156
+0.4% +$46.5K
SWKS icon
32
Skyworks Solutions
SWKS
$9.25B
$12.4M 1.33%
110,214
-1,336
-1% -$131K
WSO icon
33
Watsco Inc
WSO
$15B
$12.3M 1.32%
28,751
-3,492
-11% -$1.35M
CSGP icon
34
CoStar Group
CSGP
$12.1B
$12.3M 1.32%
140,598
+1,706
+1% +$138K
TW icon
35
Tradeweb Markets
TW
$21.6B
$12.3M 1.31%
134,886
-26,198
-16% -$2.34M
LH icon
36
Labcorp
LH
$24.4B
$12.3M 1.31%
53,905
+833
+2% +$175K
LYV icon
37
Live Nation Entertainment
LYV
$41.7B
$12.2M 1.31%
130,186
-5,200
-4% -$447K
POOL icon
38
Pool Corp
POOL
$6.76B
$12.1M 1.3%
30,429
-2,447
-7% -$858K
MSCI icon
39
MSCI
MSCI
$41.2B
$11.9M 1.28%
21,111
-2,286
-10% -$1.18M
EW icon
40
Edwards Lifesciences
EW
$47.2B
$11.9M 1.28%
156,043
+18,652
+14% +$1.3M
DLB icon
41
Dolby
DLB
$4.81B
$11.8M 1.26%
136,728
-10,513
-7% -$887K
DPZ icon
42
Domino's
DPZ
$11.5B
$11.8M 1.26%
28,580
-4,191
-13% -$1.57M
TYL icon
43
Tyler Technologies
TYL
$13.1B
$11.7M 1.26%
28,001
-1,594
-5% -$637K
TER icon
44
Teradyne
TER
$50.6B
$11.7M 1.25%
107,703
+103,878
+2,716% +$9.85M
WSC icon
45
WillScot Mobile Mini Holdings
WSC
$4.84B
$11.6M 1.24%
259,934
-3,422
-1% -$138K
SBUX icon
46
Starbucks
SBUX
$119B
$11.4M 1.22%
118,901
-5,608
-5% -$546K
VRSN icon
47
VeriSign
VRSN
$25B
$11M 1.18%
53,376
-2,266
-4% -$472K
FWONK icon
48
Liberty Media Series C
FWONK
$24.7B
$11M 1.17%
173,524
+9,107
+6% +$596K
MKL icon
49
Markel Group
MKL
$25.2B
$10.4M 1.12%
7,343
-601
-8% -$853K
ALGN icon
50
Align Technology
ALGN
$12.1B
$9.7M 1.04%
35,410
+468
+1% +$111K

Similar funds

2Xideas's Q4 2023 Portfolio in Review

As of Q4 2023, 2Xideas held 60 positions worth $933M, up 3.2% from $904M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

2Xideas withdrew a net $89.1M in Q4 2023, closing 8 positions and reducing 34 holdings. Its most notable exit was Morningstar, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, 2Xideas opened a new position in Brookfield Asset Management worth $21.7M.

  • 2Xideas's largest Q4 2023 buy was Brookfield Asset Management: 536,600 shares worth $21.7M.
  • 2Xideas added most to Teradyne in Q4 2023, an estimated $9.85M increase.
  • 2Xideas's biggest Q4 2023 reduction was Fastenal, cutting an estimated $8.42M.
  • 2Xideas fully exited Morningstar in Q4 2023, selling an estimated $12.8M.
  • 2Xideas's ten largest holdings make up 41% of its $933M portfolio in Q4 2023.
  • 2Xideas opened 2 new positions and closed 8 in Q4 2023.
  • 2Xideas's portfolio value rose 3.2% quarter-over-quarter to $933M.

Based on 2Xideas's 13F filing for Q4 2023, filed 14 Feb 2024.